2-38074520-CG-CGG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000104.4(CYP1B1):c.868dupC(p.Arg290fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,608,236 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
CYP1B1
NM_000104.4 frameshift
NM_000104.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.35
Genes affected
CYP1B1 (HGNC:2597): (cytochrome P450 family 1 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 87 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-38074520-C-CG is Pathogenic according to our data. Variant chr2-38074520-C-CG is described in ClinVar as [Pathogenic]. Clinvar id is 68468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP1B1 | NM_000104.4 | c.868dupC | p.Arg290fs | frameshift_variant | 2/3 | ENST00000610745.5 | NP_000095.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP1B1 | ENST00000610745.5 | c.868dupC | p.Arg290fs | frameshift_variant | 2/3 | 1 | NM_000104.4 | ENSP00000478561.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152154Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
152154
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000258 AC: 6AN: 232956Hom.: 0 AF XY: 0.0000395 AC XY: 5AN XY: 126728
GnomAD3 exomes
AF:
AC:
6
AN:
232956
Hom.:
AF XY:
AC XY:
5
AN XY:
126728
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1456082Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 723902
GnomAD4 exome
AF:
AC:
27
AN:
1456082
Hom.:
Cov.:
31
AF XY:
AC XY:
15
AN XY:
723902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74332
GnomAD4 genome
AF:
AC:
5
AN:
152154
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:8Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glaucoma 3A Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 1997 | - - |
Pathogenic, no assertion criteria provided | research | Institute of Basic Medical Sciences, Khyber Medical University, Peshawar | Dec 06, 2023 | A known frameshift homozygous mutation, c.868dupC was identified in CYP1B1 gene in Pakistani families. Later on, segregation studies also confirmed the mutation in other affected individuals in homozygous state while found in heterozygous pattern in parents and other normal siblings. All patients had uncontrollable IOP and bilateral corneal opacity with no perception of light. all the carriers of c.868dupC were phenotypically normal. Reference PMID: 30820150 - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 07, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2021 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 30820150, 24281366, 25091052, 17893647, 17591938, 25018621, 9097971, 25950505, 31589614) - |
Glaucoma 3A;C4310623:Anterior segment dysgenesis 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 20, 2024 | - - |
Anterior segment dysgenesis 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 25, 2024 | - - |
CYP1B1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 16, 2018 | The CYP1B1 c.868dupC (p.Arg290ProfsTer37) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Arg290ProfsTer37 variant has been reported in at least five studies and is found in a total of 11 individuals from six families including ten in a homozygous state and one in a compound heterozygous state (Stoilov et al. 1997; Bagiyeva et al. 2007; Micheal et al. 2014; Prokudin et al. 2014; Souzeau et al. 2015). The compound heterozygous proband presented with iris and fundal colobomas and micropthalmia. Of note, the proband's mildly affected brother did not have the p.Arg290ProfsTer37 variant and therefore the variant's contribution to disease is difficult to ascertain in this family (Prokudin et al. 2014). One affected homozygous individual presented with juvenile open-angle glaucoma, not primary congenital glaucoma (Souzeau et al. 2015). The p.Arg290ProfsTer37 variant was absent from 690 controls and is reported at a frequency of 0.00008 in the European (non-Finnish) population of the Exome Aggregation Consortium. Due to the potential impact of frameshift variants and the evidence in the literature, the p.Arg290ProfsTer37 variant is classified as pathogenic for CYP1B1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Congenital glaucoma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2023 | This sequence change creates a premature translational stop signal (p.Arg290Profs*37) in the CYP1B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP1B1 are known to be pathogenic (PMID: 9097971, 9497261, 19234632). This variant is present in population databases (rs587778875, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with primary congenital glaucoma or juvenile open angle glaucoma (PMID: 9097971, 17591938, 25091052, 25950505). It has also been observed to segregate with disease in related individuals. This variant is also known as c.862insC and single cytosine base insertion (nt 1209- 1214). ClinVar contains an entry for this variant (Variation ID: 68468). For these reasons, this variant has been classified as Pathogenic. - |
Congenital ocular coloboma Uncertain:1
Uncertain significance, no assertion criteria provided | research | Eye Genetics Research Group, Children's Medical Research Institute | Mar 30, 2012 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at